New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.

Abstract

Although new salicylates are now available for the treatment of ulcerative colitis, sulphasazaline still has an important therapeutic role. The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission. New steroids are a real alternative to traditional steroids in… (More)

Topics

1 Figure or Table

Slides referencing similar topics